Bioexx Proteins (BIXZF) 0.0002 $BIXZF
Rwanda Debit Cards: Market Update
M2 - Fri Feb 14, 2:30AM CST
Synopsis
Future of Serbia Oil Refinery Markets to 2020
M2 - Fri Feb 14, 2:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/jhjn55/future_of_serbia) has announced the addition of the "Future of serbia Oil Refinery Markets to 2020- Outlook of Investments, Business Opportunities, Infrastructure, Petroleum Products, Supply- Demand and Competition" report to their offering. The report provides complete analysis into the serbia refining industry amidst the rapid developments in the recent past. All key trends, drivers and challenges of investing/ entering/ operating in the industry are detailed. Details of all operational and planned refineries including location, start up, operator, owners, constructors, capital investments, project feasibility and configuration are provided in the report. Further, outlook of Crude Distillation Units, Coking Unit Capacity, Fluid Catalytic Cracking Capacity and HydroCracking Unit Capacity are provided to 2020. In addition, business strategies of key refiners in the country along with their net equity weighted primary and secondary unit capacities are provided. It identifies all key investment opportunities in serbia refining market and also analyzes all the upcoming refineries in detail. It updates the major deals and events in the industry from 2012 to 2013. Scope - All potential opportunities and challenges for foreign companies to 2020 - LPG, Gasoline, Diesel, Kerosene production and consumption outlook, 2002- 2020 - Refinery wise CDU, Coking, FCC, HCC Capacity Outlook, 2005- 2020 - Share of the country in Region and Global Refining Capacities, 2013 - Market Drivers, Trends, Outlook and Challenges of operating in refining industry - Refinery details including location, operator, owners, start up, complexity, investment, construction, current status - Business and expansion strategies of leading Refining companies - Profiles of three leading refiners including overview, SWOT, Business description and final analysis - All major oil and gas news, deals and events along with their impact on the industry Reasons to Purchase - Formulate focused investment and development strategies over the next decade - Make strategic and financial decisions based on industry trends and capital expenditure forecasts - Identify key investment opportunities through detailed information on upcoming refineries and capacity information forecasts - Develop clear and complete understanding of the industry through asset by asset historic and forecasted information - Detailed Market Shares, company wise capacities and information on nature of industry allows you to easily beat your competition - Identify the success strategies and financial status of key companies operating in the industry along with their strengths and weaknesses For more information visit http://www.researchandmarkets.com/research/jh..._of_serbia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
BioExx Announces Novel Food Status & Company Sale Process Update
Marketwire - Tue Nov 05, 4:31PM CST
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), announces that the European Food Safety Authority ("EFSA"), has concluded their scientific opinion on the safety of Isolexx(TM) "rapeseed (canola) protein isolate" as a Novel Food Ingredient. The panel concluded that the rapeseed protein isolate is safe under BioExx's proposed uses and use levels and that the biological value of rapeseed and soy protein, determined by the PDCAAS (protein digestibility corrected amino acid score), appears to be similar.
BioExx Announces Scheduled Delisting From the Toronto Stock Exchange
Marketwire - Wed Oct 09, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), announces that the Toronto Stock Exchange (the "TSX") has informed the Company that effective November 6, 2013 the Company's common shares will be delisted from the TSX for failure to meet the continued listing requirements of the TSX. Trading in the Company's common shares will remain suspended. It is anticipated that the Company's common shares will be duly delisted on November 6, 2013.
BioExx Specialty Proteins Announces Change in Management
Marketwire - Thu Aug 29, 6:30AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that its board of directors (the "Board") has appointed John MacDonald, currently a director of the Company, to serve as Interim Chief Executive Officer of the Company. The Board wishes to express its gratitude to Chris Schnarr, the previous Chief Executive Officer of the Company, who has also resigned from the Board.
BioExx Announces Q2 2013 Results
Marketwire - Fri Aug 16, 4:32PM CDT
BioExx Specialty Proteins Ltd. (TSX: BXI) today announced its financial results for the three and six months ended June 30, 2013.
BioExx Engages Advisor for Sale of Company
Marketwire - Tue Jul 30, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI) today announced that it has engaged Ernst & Young Orenda Corporate Finance Inc. to undertake a process to explore a sale of the Company and, if feasible and subject to shareholder approval, to sell the Company.
BioExx Closes First Saskatoon Asset Sale for $3.5M
Marketwire - Mon Jul 22, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI) today announced that it has closed its previously announced sale of certain equipment assets from its Saskatoon facility, for gross proceeds of $3.5 million.
BioExx Provides Update on Saskatoon Asset Sales
Marketwire - Tue Jul 09, 7:32AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that it has signed binding purchase agreements with two purchasers for its Saskatoon land, building, and equipment, for a combined total of approximately $11.0 million, subject to customary terms and approvals. As previously announced, the Company is discontinuing operations at its Saskatoon facility.
BioExx Announces Election of Directors
Marketwire - Wed Jun 26, 6:20AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that the nominees listed in the management proxy circular for the 2013 Annual and Special Meeting of Shareholders (the "Meeting") were elected as directors of the Corporation. Detailed results of the votes by proxy for the election of directors held at the Meeting today in Toronto are set out below.
BioExx Receives Notices of Allowance for Two U.S. Protein Patent Applications
Marketwire - Tue Jun 18, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that it has received two Notices of Allowance from the United States Patent and Trademark Office ("USPTO") for two separate patent applications related to its canola and rapeseed protein products and processing technologies. A Notice of Allowance from the USPTO is a written notification that a patent application has cleared internal review and is pending issuance.
Rwanda Debit Cards: Market Update
M2 - Fri Feb 14, 2:30AM CST
Synopsis
Future of Serbia Oil Refinery Markets to 2020
M2 - Fri Feb 14, 2:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/jhjn55/future_of_serbia) has announced the addition of the "Future of serbia Oil Refinery Markets to 2020- Outlook of Investments, Business Opportunities, Infrastructure, Petroleum Products, Supply- Demand and Competition" report to their offering. The report provides complete analysis into the serbia refining industry amidst the rapid developments in the recent past. All key trends, drivers and challenges of investing/ entering/ operating in the industry are detailed. Details of all operational and planned refineries including location, start up, operator, owners, constructors, capital investments, project feasibility and configuration are provided in the report. Further, outlook of Crude Distillation Units, Coking Unit Capacity, Fluid Catalytic Cracking Capacity and HydroCracking Unit Capacity are provided to 2020. In addition, business strategies of key refiners in the country along with their net equity weighted primary and secondary unit capacities are provided. It identifies all key investment opportunities in serbia refining market and also analyzes all the upcoming refineries in detail. It updates the major deals and events in the industry from 2012 to 2013. Scope - All potential opportunities and challenges for foreign companies to 2020 - LPG, Gasoline, Diesel, Kerosene production and consumption outlook, 2002- 2020 - Refinery wise CDU, Coking, FCC, HCC Capacity Outlook, 2005- 2020 - Share of the country in Region and Global Refining Capacities, 2013 - Market Drivers, Trends, Outlook and Challenges of operating in refining industry - Refinery details including location, operator, owners, start up, complexity, investment, construction, current status - Business and expansion strategies of leading Refining companies - Profiles of three leading refiners including overview, SWOT, Business description and final analysis - All major oil and gas news, deals and events along with their impact on the industry Reasons to Purchase - Formulate focused investment and development strategies over the next decade - Make strategic and financial decisions based on industry trends and capital expenditure forecasts - Identify key investment opportunities through detailed information on upcoming refineries and capacity information forecasts - Develop clear and complete understanding of the industry through asset by asset historic and forecasted information - Detailed Market Shares, company wise capacities and information on nature of industry allows you to easily beat your competition - Identify the success strategies and financial status of key companies operating in the industry along with their strengths and weaknesses For more information visit http://www.researchandmarkets.com/research/jh..._of_serbia About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
BioExx Announces Novel Food Status & Company Sale Process Update
Marketwire - Tue Nov 05, 4:31PM CST
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), announces that the European Food Safety Authority ("EFSA"), has concluded their scientific opinion on the safety of Isolexx(TM) "rapeseed (canola) protein isolate" as a Novel Food Ingredient. The panel concluded that the rapeseed protein isolate is safe under BioExx's proposed uses and use levels and that the biological value of rapeseed and soy protein, determined by the PDCAAS (protein digestibility corrected amino acid score), appears to be similar.
BioExx Announces Scheduled Delisting From the Toronto Stock Exchange
Marketwire - Wed Oct 09, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), announces that the Toronto Stock Exchange (the "TSX") has informed the Company that effective November 6, 2013 the Company's common shares will be delisted from the TSX for failure to meet the continued listing requirements of the TSX. Trading in the Company's common shares will remain suspended. It is anticipated that the Company's common shares will be duly delisted on November 6, 2013.
BioExx Specialty Proteins Announces Change in Management
Marketwire - Thu Aug 29, 6:30AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that its board of directors (the "Board") has appointed John MacDonald, currently a director of the Company, to serve as Interim Chief Executive Officer of the Company. The Board wishes to express its gratitude to Chris Schnarr, the previous Chief Executive Officer of the Company, who has also resigned from the Board.
BioExx Announces Q2 2013 Results
Marketwire - Fri Aug 16, 4:32PM CDT
BioExx Specialty Proteins Ltd. (TSX: BXI) today announced its financial results for the three and six months ended June 30, 2013.
BioExx Engages Advisor for Sale of Company
Marketwire - Tue Jul 30, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI) today announced that it has engaged Ernst & Young Orenda Corporate Finance Inc. to undertake a process to explore a sale of the Company and, if feasible and subject to shareholder approval, to sell the Company.
BioExx Closes First Saskatoon Asset Sale for $3.5M
Marketwire - Mon Jul 22, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI) today announced that it has closed its previously announced sale of certain equipment assets from its Saskatoon facility, for gross proceeds of $3.5 million.
BioExx Provides Update on Saskatoon Asset Sales
Marketwire - Tue Jul 09, 7:32AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that it has signed binding purchase agreements with two purchasers for its Saskatoon land, building, and equipment, for a combined total of approximately $11.0 million, subject to customary terms and approvals. As previously announced, the Company is discontinuing operations at its Saskatoon facility.
BioExx Announces Election of Directors
Marketwire - Wed Jun 26, 6:20AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that the nominees listed in the management proxy circular for the 2013 Annual and Special Meeting of Shareholders (the "Meeting") were elected as directors of the Corporation. Detailed results of the votes by proxy for the election of directors held at the Meeting today in Toronto are set out below.
BioExx Receives Notices of Allowance for Two U.S. Protein Patent Applications
Marketwire - Tue Jun 18, 6:01AM CDT
BioExx Specialty Proteins Ltd. ("BioExx" or the "Company") (TSX: BXI), today announced that it has received two Notices of Allowance from the United States Patent and Trademark Office ("USPTO") for two separate patent applications related to its canola and rapeseed protein products and processing technologies. A Notice of Allowance from the USPTO is a written notification that a patent application has cleared internal review and is pending issuance.
